CORE--ADENOVIRUS FACILITY
$184,121P01FY2001CANIH
Virginia Commonwealth University, Richmond VA
Investigators
Linked publications & trials
Paper 22178615Paper 21726915Paper 21666281Paper 21647438Paper 21263216Paper 21172423Paper 20584581Paper 20499882Paper 20368801Paper 19808981Paper 19420065Paper 19252415Paper 19211312Paper 18614762Paper 18440975Paper 18217691Paper 17912425Paper 17910475Paper 17540843Paper 17526517Paper 17363476Paper 17308059Paper 17283137Paper 17264303Paper 17259563Paper 17218385Paper 17200418Paper 17050804Paper 16622074Paper 16609040Paper 16464504Paper 16317705Paper 16267617Paper 16227403Paper 16207485Paper 16015388Paper 15880678Paper 15713897Paper 15713896Paper 15708852Paper 15684422Paper 15655348Paper 15580305Paper 15475464Paper 15450724Paper 15382121Paper 15197348Paper 15175350Paper 14767998Paper 14744854Paper 14678967Paper 14508078Paper 12960112Paper 12947395Paper 12947392Paper 12947387Paper 12947383Paper 12944901Paper 12902904Paper 12824521Paper 12734192Paper 12697808Paper 12661154Paper 12481713Paper 12134064Paper 12118331Paper 12085347Paper 12066887Paper 12037685Paper 11995427Paper 11915023Paper 11856735Paper 11849808Paper 11716072Paper 11697324Paper 11679961Paper 11578655Paper 11553704Paper 11416113Paper 11400343Paper 11358802Paper 11341530Paper 11313882Paper 11309321Paper 11297265Paper 11264178Paper 11057740Paper 11020446Paper 10997587Paper 10880018Paper 10830725Paper 10760996Paper 10725858Paper 10669545Paper 10639586
Abstract
DESCRIPTION: (Applicant's Description) The Adenovirus Core will generate the proposed recombinant adenoviruses for each of the individual projects, including screening of clones and limited characterization in vitro. Selected adenoviruses will be grown in medium scale production and purified to be used for the proposed in vitro and in vivo studies. Testing for replication competent adenoviruses (RCA) will be performed.
View original record on NIH RePORTER →